In contrast, it is reported that activation of Dectin-1 and other members of the CLR family such as Mannose Receptor (CD206) results in tumour progression and an immunosuppressive phenotype in the TME [17, 27, 28]. The gene discussed is DCLK3; the disease is neoplasm.